Atsushi Kurihara

4.6k citations

88 papers · 3.7k indexed · 1 hit paper · h-index 29

Cardiology and Cardiovascular Medicine top 1%
Pharmacology top 1%
Pharmacology top 0.2%
Molecular Biology
Surgery top 5%

Co-authors: Nagy A. Farid Osamu Okazaki Katsunobu Hagihara Toshihiko Ikeda Steven Wrighton Miho Kazui Yumi Nishiya William M. Pardridge
Topics: Inflammatory mediators and NSAID effects (21 papers)Antiplatelet Therapy and Cardiovascular Diseases (20 papers)Pharmacogenetics and Drug Metabolism (19 papers)
Cited by: Internal Medicine Pharmacology Cardiology and Cardiovascular Medicine
Journals: Journal of Biological Chemistry Circulation Journal of Neuroscience
Partner nations: Japan United States Germany

In The Last Decade

Atsushi Kurihara

87 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of the Human Cytochrome P450 Enzymes Involved in the Two Oxidative Steps in the Bioactivation of Clopidogrel to Its Pharmacologically Active Metabolite

2009 628 citations Miho Kazui, Tomoko Ishizuka et al. Drug Metabolism and Disposition profile →

Peers

Countries citing papers authored by Atsushi Kurihara

Since Specialization

Citations

This map shows the geographic impact of Atsushi Kurihara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Kurihara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Kurihara more than expected).

Fields of papers citing papers by Atsushi Kurihara

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Atsushi Kurihara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Kurihara. The network helps show where Atsushi Kurihara may publish in the future.

Co-authorship network of co-authors of Atsushi Kurihara

This figure shows the co-authorship network connecting the top 25 collaborators of Atsushi Kurihara. A scholar is included among the top collaborators of Atsushi Kurihara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Atsushi Kurihara. Atsushi Kurihara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	6β-Hydroxycortisol Is an Endogenous Probe for Evaluation of Drug–Drug Interactions Involving a Multispecific Renal Organic Anion Transporter, OAT3/SLC22A8, in Healthy Subjects 2014 ·Drug Metabolism and Disposition ·(unknown),(unknown),Katja Damme,Dominik Heer,Yuji Kumagai,Kazuya Maeda,Nobuyuki Murayama,Noriko Okudaira,Atsushi Kurihara,Takashi Izumi,Yuichi Sugiyama,Hiroyuki Kusuhara	54
2	Hepatic Microsomal Thiol Methyltransferase Is Involved in Stereoselective Methylation of Pharmacologically Active Metabolite of Prasugrel 2014 ·Drug Metabolism and Disposition ·Miho Kazui,Katsunobu Hagihara,Takashi Izumi,Toshihiko Ikeda,Atsushi Kurihara	14
3	Novel Comb-Shaped PEG Modification Enhances the Osteoclastic Inhibitory Effect and Bone Delivery of Osteoprotegerin After Intravenous Administration in Ovariectomized Rats 2012 ·Pharmaceutical Research ·(unknown),(unknown),Yoshitake Furuta,Atsushi Kurihara,(unknown),Ken‐ichi Ogawara,Takashi Izumi,Osamu Okazaki,Kazutaka Higaki	4
4	Glutaredoxin Is Involved in the Formation of the Pharmacologically Active Metabolite of Clopidogrel from Its GSH Conjugate 2012 ·Drug Metabolism and Disposition ·Katsunobu Hagihara,Miho Kazui,Atsushi Kurihara,Toshihiko Ikeda,Takashi Izumi	7
5	Prediction of Human Pharmacokinetics of Therapeutic Monoclonal Antibodies from Simple Allometry of Monkey Data 2011 ·Drug Metabolism and Pharmacokinetics ·Masataka Oitate,Noriko Masubuchi,Takashi Ito,Yoshiyuki Yabe,Tsuyoshi Karibe,Takanori Aoki,Nobuyuki Murayama,Atsushi Kurihara,Noriko Okudaira,Takashi Izumi	60
6	Glutaredoxin and Thioredoxin Can Be Involved in Producing the Pharmacologically Active Metabolite of a Thienopyridine Antiplatelet Agent, Prasugrel 2010 ·Drug Metabolism and Disposition ·Katsunobu Hagihara,Miho Kazui,Atsushi Kurihara,Kazuishi Kubota,Toshihiko Ikeda	10
7	The Intestine As an Important Contributor to Prasugrel Active Metabolite Formation In Vivo 2010 ·Drug Metabolism and Disposition ·Katsunobu Hagihara,Miho Kazui,(unknown),(unknown),(unknown),Takashi Izumi,Toshihiko Ikeda,Atsushi Kurihara	9
8	Human Carboxymethylenebutenolidase as a Bioactivating Hydrolase of Olmesartan Medoxomil in Liver and Intestine 2010 ·Journal of Biological Chemistry ·Tomoko Ishizuka,(unknown),Mitsunori Kato,(unknown),Motoko Saito,Yasushi Yoshigae,Kazuishi Kubota,Atsushi Kurihara,Takashi Izumi,Toshihiko Ikeda,Osamu Okazaki	48
9	A Possible Mechanism for the Differences in Efficiency and Variability of Active Metabolite Formation from Thienopyridine Antiplatelet Agents, Prasugrel and Clopidogrel 2009 ·Drug Metabolism and Disposition ·Katsunobu Hagihara,Miho Kazui,Atsushi Kurihara,(unknown),(unknown),Osamu Okazaki,Nagy A. Farid,Toshihiko Ikeda	97
10	Pharmacokinetics and disposition of recombinant human osteoprotegerin (rhOPG) after intravenous administration in female fischer rats 2009 ·Xenobiotica ·(unknown),Atsushi Kurihara,Emi Kamiyama,(unknown),(unknown),Osamu Okazaki	6
11	Highly frequent anti‐idiotype antibody in cynomolgus monkeys developed against mouse‐derived regions of anti‐Fas antibody humanized by complementarity determining region grafting 2009 ·British Journal of Pharmacology ·(unknown),Yasushi Yoshigae,Wataru Takasaki,Atsushi Kurihara,T. Ikeda,Osamu Okazaki	3
12	Comparison of formation of thiolactones and active metabolites of prasugrel and clopidogrel in rats and dogs 2009 ·Xenobiotica ·Katsunobu Hagihara,Miho Kazui,(unknown),Takashi Nanba,(unknown),Makoto Takahashi,Atsushi Kurihara,Osamu Okazaki,Nazar Farid,T. Ikeda	30
13	Abstract 4020: A Possible Mechanism of Poorer and more Variable Response to Clopidogrel than Prasugrel 2008 ·Circulation ·Katsunobu Hagihara,Miho Kazui,(unknown),(unknown),Nagy A. Farid,Atsushi Kurihara	3
14	Tissue distribution of humanized anti-human Fas monoclonal antibody (R-125224) based on fas antigen–antibody reaction in collagen-induced arthritis monkeys 2007 ·Life Sciences ·Motoko Saito,Yasushi Yoshigae,Jun‐ichi Nakayama,(unknown),Masahiko Ohtsuki,Atsushi Kurihara,Toshihiko Ikeda	6
15	Inhibitory Effects of Angiotensin Receptor Blockers on CYP2C9 Activity in Human Liver Microsomes 2007 ·Drug Metabolism and Pharmacokinetics ·Emi Kamiyama,Yasushi Yoshigae,Atsushi Kasuya,Makoto Takei,Atsushi Kurihara,Toshihiko Ikeda	24
16	The greater in vivo antiplatelet effects of prasugrel as compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to that of clopidogrel’s active metabolite 2007 ·Journal of Thrombosis and Haemostasis ·Atsuhiro Sugidachi,Taketoshi Ogawa,Atsushi Kurihara,Katsunobu Hagihara,Joseph A. Jakubowski,Masami Hashimoto,Y. Niitsu,Fumitoshi Asai	165
17	Brain Insulin Impairs Amyloid-β(1-40) Clearance from the Brain 2004 ·Journal of Neuroscience ·(unknown),Sumio Ohtsuki,Atsushi Kurihara,Hideo Naganuma,Kenji Nishimura,Masanori Tachikawa,Ken‐ichi Hosoya,Tetsuya Terasaki	84
18	Species Variation in Pharmacokinetics and Opsonization of Palmitoyl Rhizoxin (RS-1541) Incorporated in Lipid Emulsions 1998 ·Journal of drug targeting ·Atsushi Kurihara,(unknown),(unknown),Masaru Ikeda,Masafumi Hisaoka	2
19	Enhanced Tumor Delivery and Antitumor Activity of Palmitoyl Rhizoxin Using Stable Lipid Emulsions in Mice 1996 ·Pharmaceutical Research ·Atsushi Kurihara,(unknown),(unknown),Akiko Yasuno,Masaru Ikeda,(unknown),Tomowo Kobayashi,Masafumi Hisaoka	22
20	Pharmacokinetics of Highly Lipophilic Antitumor Agent Palmitoyl Rhizoxin Incorporated in Lipid Emulsions in Rats. 1996 ·Biological and Pharmaceutical Bulletin ·Atsushi Kurihara,(unknown),(unknown),Akiko Yasuno,Masaru Ikeda,Masafumi Hisaoka	24

About Atsushi Kurihara

Atsushi Kurihara is a scholar working on Pharmacology, Pharmacology and Cardiology and Cardiovascular Medicine, having authored 88 papers that have together received 3.7k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (21 papers), Antiplatelet Therapy and Cardiovascular Diseases (20 papers) and Pharmacogenetics and Drug Metabolism (19 papers). The work is most often cited by research in Internal Medicine (336 citations), Pharmacology (766 citations) and Cardiology and Cardiovascular Medicine (1.6k citations). Atsushi Kurihara has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include Nagy A. Farid, Osamu Okazaki, Katsunobu Hagihara, Toshihiko Ikeda, Steven Wrighton, Miho Kazui, Yumi Nishiya, William M. Pardridge, Tomoko Ishizuka and Noriko Okudaira. Their work appears in journals such as Journal of Biological Chemistry, Circulation and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact